NCT03867916View on ClinicalTrials.gov

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

December 13, 2018

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions
CaregiverMalignant NeoplasmPhysicianStage I Colorectal Cancer AJCC v8Stage I Liver CancerStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage II Liver CancerStage II Lung Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Colorectal Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage IIC Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8Stage III Liver CancerStage III Lung Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Colorectal Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8
Interventions
BEHAVIORAL

Patient Navigation Program

Use patient navigation program

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of California, San Francisco

OTHER